NASDAQ
Neuphoria Therapeutics Inc. (NEUP) has a current ratio of 3.56x as of Monday, May 25, 2026. This represents a 57.92% decrease compared to its 12-month average of 8.47x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.